Frequency of hereditary non-polyposis colorectal cancer among Uruguayan patients with colorectal cancer

Clinical Genetics

Volumn 68, Issue 1, 2005, Pages 80-87

  Sarroca, C ^a   Della Valle, Adriana ^a,b,e   Fresco, R ^b   Renkonen, E ^c   Peltomaki P ^c   Lynch, H T ^d  

^a HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS   (Uruguay)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^c UNIVERSITY OF HELSINKI   (Finland)

^d CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE   (Uruguay)

Author keywords

Frequency; Hereditary non polyposis colorectal cancer; hMLH1; hMSH2; hMSH6; Uruguay

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADULT; AGED; ARTICLE; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URUGUAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POINT MUTATION; PROTO-ONCOGENE PROTEINS; SURVIVAL RATE; URUGUAY;

EID: 20944443555     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2005.00458.x     Document Type: Article

References (54)

1. Katballe N, Christensen M, Wikman FP, Orntoft TF, Laurberg S. Frequency of hereditary nonpolyposis colorectal cancer in Danish colorectal cancer patients. Gut 2002: 50: 43-51.
2. de Leon MP, Pedroni M, Benatti P et al. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis. Gut 1999: 45: 32-38.
3. Solomon E. Colorectal cancer genes. Nature 1990: 343: 412-414.
4. Wang Q, Lasset C, Desseigne F et al. Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer. Hum Genet 1999: 105: 79-85.
5. Fishel R, Lescoe MK, Rao MR et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colorectal cancer. Cell 1993: 75: 1027-1038.
6. Leach FS, Nicolaides NC, Papadopoulos N et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993: 75: 1215-1225.
7. Bronner CE, Baker SM, Morrison PT et al. Mutation in the DNA mismatch repair gene homolog hMLH1 is associated with hereditary nonpolyposis colorectal cancer. Nature 1994: 368: 258-261.
8. Nicolaides NC, Papadopoulos N, Liu B et al. Mutations in two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994: 371: 75-80.
9. Aaltonen LA, Peltomaki P, Mecklin JP et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994: 54: 1645-1648.
10. Lynch HT. Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? Dis Colon Rectum 1996: 39: 109-110.
11. Farrington SM, McKinley AJ, Carothers AD et al. Evidence for an age-related influence of microsatellite instability on colorectal cancer survival. Int J Cancer 2002: 98: 844-850.
12. Instituto Nacional de Estadística, República Oriental del Uruguay. Anuario 2002: 1. (Retrieved of 17 February 2005 from http://www.ine.gub.uy/biblioteca/anuario2002/datos/1.4.2.xls).
13. Evans DG, Walsh S, Jeacock J et al. Incidence of hereditary non-polyposis colorectal cancer in a population-based study of 1137 consecutive cases of colorectal cancer. Br J Surg 1997: 84: 1281-1285.
14. Aaltonen LA. Molecular epidemiology of hereditary nonpolyposis colorectal cancer in Finland. Recent results. Cancer Res 1998: 154: 306-311.
15. Cornaggia M, Tibiletti MG, Albarello L, Taborelli M, Dalla Longa E, Capella C. Low incidence of hereditary nonpolyposis colorectal cancer syndrome in a selected area of the Lombardy Cancer Registry. Tumori 2000: 86: 439-444.
16. Bishop DT, Thomas HJ. The genetics of colorectal cancer. Cancer Surv 1990: 9: 585-604.
17. Mecklin JP. Frequency of hereditary colorectal carcinoma. Gastroenterology 1987: 93: 1021-1025.
18. Kee F, Collins BJ. How prevalent is cancer family syndrome? Gut 1991: 32: 509-512.
19. Ushio K. Hereditary non-polyposis colorectal cancer and tumorigenesis in the human body. In: Utsonomiya J, Lynch HT, eds. Hereditary colorectal cancer. Tokyo: Springer-Verlag, 1990: 107-113.
20. Mecklin JP. The frequency and clinical significance of HNPCC in Finland: a prospective multicenter study. In: Rossini FP, Lynch HT, Winawer SJ, eds. Recent progress in colorectal cancer: biology and management of high risk groups. Amsterdam: Elsevier Science, 1992: 247-251.
21. Westlake PJ, Bryant HE, Huchcroft SA, Sutherland LR. Frequency of hereditary nonpolyposis colorectal cancer in southern Alberta. Dig Dis Sci 1991: 36: 1441-1447.
22. Stephenson BM, Finan PJ, Gascoyne J, Garbett F, Murday VA, Bishop DT. Frequency of familial colorectal cancer. Br J Surg 1991: 78: 1162-1166.
23. Adebamowo CA, Adeyi O, Pyatt R, Prior TW, Chadwick RB, de la Chapelle A. Case report on hereditary non-polyposis colon cancer (HNPCC) in Nigeria. Afr J Med Med Sci 2000: 29: 71-73.
24. Pinsky PF. Does hereditary nonpolyposis colorectal cancer explain the observed excess risk of colorectal cancer associated with family history? Epidemiology 2000: 11: 297-303.
25. Cotterchio M, McKeown-Eyssen G, Sutherland H et al. Ontario familial colon cancer registry: methods and first-year response rates. Chronic Dis Can 2000: 21: 81-86.
26. Ravnik-Glavac M, Potocnik U, Glavac D. Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population. J Med Genet 2000: 37: 533-536.
27. Percesepe A, Borghi F, Menigatti M et al. Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol 2001: 19: 3944-3950.
28. Detry R. Follow-up after curative surgery for colorectal cancer. Acta Gastroenterol Belg 2001: 64: 268-271.
29. Panamerican Health Organization. Las condiciones de salud de las Américas. Washington DC: PAHO, 1998: v. 2.
30. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 1991: 34: 424-425.
31. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999: 116: 1453-1456.
32. Sarroca C. Higher cancer risk population (HCRP): experience in Uruguay. 7th International Course of Colorectal and Anal Surgery at the Italian Hospital in Buenos Aires. Supported by the Continuous Medical Education Program of the Cleveland Clinic, Buenos Aires, FL, USA, 1998.
33. Sarroca C, Della Valle A, Alfano N, Tedesco G, Domínguez A, Pouso J. Medición de los riesgos poblacionales complementarios a los criterios de Amsterdam. Cir Uruguay 2000: 70: 20-26.
34. Sarroca C, Alfano N, Bendin GT et al. Hereditary nonpolyposis colorectal cancer (Lynch syndrome II) in Uruguay. Dis Colon Rectum 2000: 43: 353-362.
35. Nyström-Lahti M, Wu Y, Moisio AL et al. DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary nonpolyposis colorectal cancer. Hum Mol Genet 1996: 5: 763-769.
36. Chadwick RB, Pyatt RE, Niemann TH et al. Hereditary and somatic DNA mismatch repair gene mutations in sporadic endometrial carcinoma. J Med Genet 2001: 38: 461-466.
37. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002: 30: e57.
38. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954: 139: 846-851.
39. Sarroca C, Peltomaki P, Alfano N et al. Three new mutations in hereditary nonpolyposis colorectal cancer (Lynch syndrome II) in Uruguay. Cancer Genet Cytogenet 2003: 142: 13-20.
40. Vassallo JA, Barrios E, De Stefani E, Ronco A. II Atlas de incidencia del cáncer en el Uruguay. Montevideo: Comisión Honoraria de Lucha contra el Cáncer, 2001: 189 pp.
41. de la Chapelle A. Microsatellite instability phenotype of tumors: genotyping or immunohistochemistry? The jury is still out. J Clin Oncol 2002: 20: 897-899.
42. Lynch HT, de la Chapelle A. Genetic susceptibility to nonpolyposis colorectal cancer. J Med Genet 1999: 36: 801-818.
43. Buerstedde JM, Alday P, Torhorst J, Weber W, Muller H, Scott R. Detection of new mutations in six out of 10 Swiss HNPCC families by genomic sequencing of the hMSH2 and hMLH1 genes. J Med Genet 1995: 32: 909-912.
44. Wijnen J, Vasen H, Khan PM, Menko FH, van der Klift H, van Leeuwen C, van den Broek M, van Leeuwen-Cornelisse I, Nagengast F, Meijers-Heijboer A, et al. Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 1995: 56: 1060-1066.
45. Wijnen J, Khan PM, Vasen H, Menko F, van der Klift H, van den Broek M, van Leeuwen-Cornelisse I, Nagengast F, Meijers-Heijboer EJ, Lindhout D, Griffioen G, Cats A, Kleibeuker J, Varesco L, Bertario L, Bisgaard ML, Mohr J, Kolodner R, Fodde R. Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am J Hum Genet 1996: 58: 300-307.
46. Weber TK, Conlon W, Petrelli NJ, Rodriguez-Bigas M, Keitz B, Pazik J, Farrell C, O'Malley L, Oshalim M, Abdo M, Anderson G, Stoler D, Yandell D. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees. Cancer Res 1997: 57: 3798-3803.
47. Liu T, Wahlberg S, Rubio C, Holmberg E, Gronberg H, Lindblom A. DGGE screening of mutations in mismatch repair genes (hMSH2 and hMLH1) in 34 Swedish families with colorectal cancer. Clin Genet 1998: 53: 131-135.
48. Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, du Sart D, Tucker K, Kirk J. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-Degative kindreds. Am J Hum Genet 2001: 68: 118-127.
49. Sans M. Genética e historia: hacia una revisión de nuestra identidad como pais de inmigrantes. Montevideo: Quinto Centenario Universidad de la República 1992. 75p.
50. Rodríguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997: 89: 219-224.
51. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, De La Chapelle A, Mecklin JP. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000: 118: 829-834.
52. Houlston RS, Collins A, Slack J, Morton NE. Dominant genes for colorectal cancer are not rare. Ann Hum Genet 1992: 56: 99-103.
53. Thorson A. G, Knezetic JA, Lynch HT. A century of progress in Hereditary nonpolyposis colorectal cancer (Lynch Syndrome). Dis Colon Rectum 1999: 42: 1-9.
54. Lin KM, Shashidharan M, Ternent CA, Thorson AG, Blatchford GJ, Christensen MA, Lanspa SJ, Lemon SJ, Watson P, Lynch HT. Colorèctal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Colon Rectum 1998: 41: 428-433.